Showing results (2201-2210 of 2,235) with videos related to

Sort By:
Pageof 224
Transplantation Proceedings|January 21, 2023
The Outcome of COVID-19 Infection on Kidney Transplantation Recipients in Southern Saudi Arabia: Single-Center ExperienceHany M El Hennawy, Omar Safar, Adel Elatreisy, et al.
Emerging Infectious Diseases|June 8, 2007
Genome analysis linking recent European and African influenza (H5N1) virusesSteven L Salzberg, Carl Kingsford, Giovanni Cattoli, et al.
Acta Neuropathologica|January 17, 2024
Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseasesWeiguanliu Zhang, Christina D Orrú, Aaron Foutz, et al.
Clinical Nuclear Medicine|June 11, 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T CellsPierre Sesques, Jérémie Tordo, Emmanuelle Ferrant, et al.
The Journal of Biological Chemistry|September 16, 2015
Resistance of Dynamin-related Protein 1 Oligomers to Disassembly Impairs Mitophagy, Resulting in Myocardial Inflammation and Heart FailureThomas J Cahill, Vincenzo Leo, Matthew Kelly, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2022
Gender Differences in Smoking Attitude among Saudi Medical StudentsAli Hassan A Alnasser, Jaffar A Al-Tawfiq, Rawan Maatouk A Kheimi, et al.
Pediatric Endocrinology Reviews : PER|May 29, 2018
Meeting Report: Growth and Social Environment. Proceedings of the 25th Aschauer Soiree, held at Krobielowice, Poland, November 18th 2017Slawomir Kozie, Christiane Scheffler, Janina Tutkuviene, et al.
Journal of Neuropathology and Experimental Neurology|October 1, 2020
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and UnknownsDavid M Asher, Ermias Belay, Eileen Bigio, et al.
Blood Advances|January 26, 2021
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphomaFrançois Lemonnier, Violaine Safar, Asma Beldi-Ferchiou, et al.
Blood Cancer Journal|April 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA studyClémentine Sarkozy, Loïc Chartier, Vincent Ribrag, et al.
Pageof 224